Lumos Diagnostics falls, raises funds via convertible note agreements

Lumos Diagnostics Holdings

21/11/2022 01:08

** Shares of Lumos Diagnostics  LDX.AX  dip as much as 10.3%
to A$0.052, their biggest pct loss since Oct. 3
    ** Diagnostics solutions provider says it entered into
binding convertible note agreements to raise up to A$8 mln
($5.33 mln)  urn:newsml:reuters.com:*:nFWN32F00O
    ** Says funds to support co's operational requirements into
first half of FY24
    ** Says if shareholder approval granted, convertible notes
will be issued in two tranches 
    ** Stock has fallen 93.8% this year, as of last close 
($1 = 1.5006 Australian dollars)
 (Reporting by Echha Jain in Bengaluru)
 ((Echha.jain@thomsonreuters.com))